Business · 20/05/2016
FDA Announces Upcoming Blood Products Advisory Committee Meeting
The Food and Drug Administration (FDA) is scheduling a public advisory committee meeting of the Blood Products Advisory Committee to provide advice on FDA's regulatory issues, with at least one portion closed to the public.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →